Pooled safety and efficacy analysis of trifluridine/tipiracil plus bevacizumab in five clinical trials using individual data from patients with metastatic colorectal cancer
Not Applicable
- Conditions
- metastatic colorectal cancer
- Registration Number
- JPRN-UMIN000041621
- Lead Sponsor
- The 22nd Century Cutting-Edge Medical Informaion Technology Organization
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- 239
Inclusion Criteria
Not provided
Exclusion Criteria
Nothing in particular
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Incidence of adverse events Response to treatment Disease control rate Objective response rate Overall survival Progression free survival Time to treatment failure
- Secondary Outcome Measures
Name Time Method